▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #67 by analyst upside · 2026-09-27
TNON
Tenon Medical, Inc.
Healthcare · Market Cap $2M · P/E 0x
ANALYST PRICE TARGET
+1317.7%
implied upside to consensus target
Current Price $3.13
Consensus Target $44.38
Bull Target $78.75
Bear Target $10.0
Analysts Covering 2
ANALYST CONSENSUS - STRONG BUY
Strong Buy
1
Buy
1
Hold
0
Sell
0
52-Week Low $2.4
52-Week High $50.4
YTD Return -90.8%
FUNDAMENTALS
Market Cap $2M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-42.75
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $5M
Profit Margin -257.9%
52-WEEK RANGE
52-Week Low $2.4
52-Week High $50.4
Current Price $3.13
Bear Target $10.0
Bull Target $78.75
● Now $3.13 ● Target $44.38
TRADING DATA
Avg Volume 5.6M
YTD Return -90.8%
Analyst Count 2
Consensus Strong Buy
Upside to Target +1317.7%
Last Updated 2026-09-27

ANALYST SUMMARY

Tenon Medical, Inc. (TNON) is currently trading at $3.13 with a Wall Street consensus price target of $44.38, implying potential upside of 1317.7% over the next 12 months. 2 analysts currently cover TNON, with a consensus rating of Strong Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $78.75, while the most cautious has a target of $10.0.

TNON operates in the Healthcare sector with a market capitalisation of $2M. The stock is down 90.8% year-to-date and is currently trading near the lower end of its 52-week range of $2.4 – $50.4.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CNSY +1533.2%
Cerenome, Inc.
$15M · P/E 0.7x · Buy
TOVX +1033.3%
Theriva Biologics, Inc.
$10M · P/E 0.2x · Strong Buy
GTBP +988.5%
GT Biopharma, Inc.
$12M · P/E 0.1x · Buy
ETST +974.6%
Earth Science Tech, Inc.
$27M · P/E 9.3x · Hold
DWTX +929.4%
Dogwood Therapeutics, Inc.
$46M · P/E 0.7x · Strong Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for TNON, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Alliance Global Partners ● Initiated
Buy 2025-04-09 14% win rate (7 calls)
Maxim Group - Reiterated
Buy → Buy 2024-11-15 28% win rate (40 calls)
Benchmark reit
Speculative Buy → Speculative Buy 2024-08-14 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
35
out of 100
Coverage depth
8/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →